General Updates

Registered Office: KCI Plaza, 6th Floor KANORIA CHEMICALS & INDUSTRIES LIMITED 23C, Ashutosh Chowdhury Avenue Kolkata-700 019 Tel: +9 I-33-403 1-3200 CIN :L24110WB1960PLC024910 E-mail: calall@kanoriachem.com Website:www.kanoriachem.com KC-13/ Date: 02.09.2026 To, To, The Manager, The Secretary, Listing Department SSELimited National Stock Exchange of India Limited PhirozeJeejeebhoy Towers Exchange Plaza, C-1, Siock G, Dalal Street, Mumbai - 400 001 Sandra Kurla Complex, Script Code: 506525 Sandra (E), Mumbai - 400 051 Symbol: KANORICHEM Dear Sir, SJ.IJz: AGM presentation We are attaching herewith the presentation made to the Shareholders at the 66th Annual General Meeting of the Company today, i.e. 2nd September, 2026. The same will also be hosted on the website of the Company. This isfor your information and records. Thanking you, Yours Sincerely, For Kanoria Chemicals &Industries Limited Pratibha Jaiswal Company Secretary Encl.: asabove CorporateOffice: IndraPrakash,21,BarakhambaRoad,NewDelhi- 110001,Tel: 91-11-4357-9200,Fax: 91-11-2371-7203,2376·6486 66th Annual General Meeting September 02, 2026 Disclaimer Except for historical information and discussions contained herein, statements included in this presentation may constitute “forward looking statements”. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ from those that may be projected by these forward looking statements. Kanoria Chemicals & Industries Limited undertakes no obligation to update forward looking statements to reflect events and circumstances after the date thereof. EY IGHLIGHTS FY’ 2025-26  Improved efficiencies and volumes (INR in lakhs) FY'2026 FY'2025  Operating Revenue increased by 29% Operating Revenue 87,534 67,830 Other Income 2,689 1,425  EBITDA increased by 52% with margins EBITDA 8,158 5 ,358 increasing to 9.3% as against 7.9% in FY’2025 Finance Cost 1,945 1,607 EBTDA 6,213 3 ,751  EBTDA (mostly representing cash profit) Depreciation 2,281 1,997 improved by 66% EBT & Exceptional Item 3,931 1 ,754  Exceptional Item represents non cash Exceptional Item 1,064 4,499 EBT from Cont. Operations 2,867 (2,745) impairment loss of investments in APAG Tax (574) 1,143 Holding AG (erstwhile subsidiary) Profit from Cont. Operations 3,441 (3,888)  Negative tax on reversal of Deferred Tax by Rs. Profit from Discont. Operations - 90 2143 lakhs due to transition under ‘New Tax Net Profit 3,441 (3,798) OCI 252 (7) Regime’ TCI 3,693 (3,805) EPS (INR) 7.88 (8.69) Operating Revenue Others Pentaerythritol Methanol Trading Phenol FDH Resin Hexamine Formaldehyde(37%) (INR in lakhs) FY'2026 FY'2025  Delivered much stronger performance with Operating Revenue 10,608 7,601 improved capacity utilisation and sales volmes. Other Income 259 797  Operating Revenue increased by 40% EBITDA 1,925 128 Finance Cost 1,956 2,049  EBITDA increased over 14 times with margins EBTDA (31) (1,921) increasing to 18.1% as against 1.7% in FY’2025 Depreciation 1,236 1,194 EBT (1,267) (3,115) Net Profit (1,267) (3,115) Consolidated Profitability (INR in lakhs)  Operating Revenue increased by 30% FY'2026 FY'2025 Operating Revenue 98,143 75,431  EBITDA increased by 90% Other Income 2,245 1,673  APAG Holding AG, Switzerland ceased to be EBITDA 9,379 4,936 subsidiary of the Company during the year and Finance Cost 3,197 3,106 EBTDA 6,182 1,830 its results are shown under Discontinued Depreciation 3,517 3,191 Opeartions which include Gain on Loss of EBT & Exceptional Item 2,665 (1,361) Control of Rs. 9,765 lakhs Exceptional Item - 2,944 EBT from Cont. Operations 2,665 (4,306) Tax (574) 1,143 Profit from Cont. Operations 3,239 (5,449) Profit from Discont. Operations 8,081 (5,366) Net Profit 11,319 (10,815) OCI 3,106 808 TCI 14,426 (10,007) EPS (INR) 27.64 (19.13) UTURE OUTLOOK  ‘Vision 2030’ roadmap aimed at sustainable growth and improved profitability under way as planned  Favourable business prospects with increasing industrial activity and growing demand from Company’s customers segment  Projects involving diversification in speciality chemicals Triacetin and Penta Derivatives are expected to be commissioned shortly.  Actively pursuing capacity addition in Formaldehyde and Resin .  Continuing thrust on programmes involving process and supply chain improvement and cost reduction programme.  Threat from Geopolitical situation and high tariffs  Promoters contributing INR 49.5 crores through 7% NCRPS  Backed by a slew of liberalisation measures announced by Ethiopian Government last fiscal KAT is expected to continue delivering improved performane  Evaluating addition in weaving capacity; with surplus capacity available in other departments incremental Capex will be moderate  Exposed to threat from currency volatility, inflation and changes in Government policy in Ethiopia T H A N K Y O U